Jpmorgan Healthcare Leaders Etf Beta
| JDOC Etf | 57.49 0.26 0.45% |
JPMorgan Healthcare Leaders fundamentals help investors to digest information that contributes to JPMorgan Healthcare's financial success or failures. It also enables traders to predict the movement of JPMorgan Etf. The fundamental analysis module provides a way to measure JPMorgan Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to JPMorgan Healthcare etf.
JPMorgan |
JPMorgan Healthcare Leaders ETF Beta Analysis
JPMorgan Healthcare's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, JPMorgan Healthcare Leaders has a Beta of 0.0. This indicator is about the same for the average (which is currently at 0.0) family and about the same as Health (which currently averages 0.0) category. This indicator is about the same for all United States etfs average (which is currently at 0.0).
JPMorgan Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses JPMorgan Healthcare's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of JPMorgan Healthcare could also be used in its relative valuation, which is a method of valuing JPMorgan Healthcare by comparing valuation metrics of similar companies.JPMorgan Healthcare is currently under evaluation in beta as compared to similar ETFs.
About JPMorgan Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze JPMorgan Healthcare Leaders's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JPMorgan Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JPMorgan Healthcare Leaders based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether JPMorgan Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of JPMorgan Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Jpmorgan Healthcare Leaders Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Jpmorgan Healthcare Leaders Etf:Check out JPMorgan Healthcare Piotroski F Score and JPMorgan Healthcare Altman Z Score analysis. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
The market value of JPMorgan Healthcare is measured differently than its book value, which is the value of JPMorgan that is recorded on the company's balance sheet. Investors also form their own opinion of JPMorgan Healthcare's value that differs from its market value or its book value, called intrinsic value, which is JPMorgan Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JPMorgan Healthcare's market value can be influenced by many factors that don't directly affect JPMorgan Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JPMorgan Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if JPMorgan Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JPMorgan Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.